Endexx Corporation (OTC Pink: EDXC) (PINKSHEETS: EDXC), a provider of innovative medical marijuana management and technology solutions, announced today that it has completed the acquisition of GreenLeaf Consulting LLC., a pioneering New Jersey consulting firm for the medical marijuana industry. Under the terms of the acquisition, Endexx has issued 3 million shares to GreenLeaf Consulting in an all-stock transaction.
GreenLeaf Consulting is currently servicing existing accounts in Connecticut and Massachusetts and recently added to its portfolio a new contract with a Chicago, Illinois, medical marijuana applicant. GreenLeaf Consulting is also in negotiations to consult for policy makers and legislators in Connecticut and Massachusetts for the formulation, adoption and implementation of medical marijuana programs at the state level.
M3Hub Seed to Sale inventory tracking and management platform will be offered as the solution for compliance tracking, program oversight and to streamline management processes and increase overall efficiencies.
Greenleaf Consulting is a full-service consulting firm with several years of experience and a proven track record in the marijuana industry. GreenLeaf Consulting provides consulting and advisory services to industry participants in several states to assist with application preparation and securing licensing. Services include business development, licensing approval, compliance, location assessment, facility design, security, equipment technology, plant management, harvesting, processing and packaging protocols. In addition GreenLeaf Consulting assists clients in formulating a strategic expansion plan that includes identification of opportunities and the development of winning strategies.
Todd Davis, Endexx CEO, stated: “GreenLeaf Consulting is a proven expert and ideal partner that puts Endexx more firmly on the path to long term revenue growth. On top of hourly rates, each consulting contract comes with an equitable interest in the ongoing operation of the underlying entity, resulting in increased ROI, profitability, operating efficiency and ultimately benefitting all customers and Endexx’s bottom line.”
Mr. Joseph Stevens, Founder and President of Greenleaf Consulting and Greenleaf Compassion Center of New Jersey, stated: "After looking at Endexx from the standpoint of valuation, products and technology development in the medical marijuana arena, I am convinced the synergy of our joint business models and the upside potential Endexx offers is an unmatchable opportunity in this exciting new industry.”
Endexx provides innovative medical marijuana management and technology solutions. The Company has two products that launched in the first half of 2014 -- the m3hub and the Autospense™. Both products provide essential solutions to promote regulatory compliance and full accountability through "seed to sale" inventory management and tracking. Based on principles developed by the pharmacological industry, the m3hub database is the first standardized software platform for tracking pharmaceutical grade marijuana to support a Centralized Medical Marijuana Industry Repository and maintain compliance with the laws of the federal government and state and local regulatory bodies. The Autospense™ is a high-tech marijuana inventory control and dispensing machine, which provides up to the minute accounting details and protects the security of the product as well as the patient. By automating the dispensing process, Autospense™ increases productivity and reduces costs for marijuana retailers, while enhancing their service quality by reducing transaction time for customers. www.endexx.com, www.m3hub.com, www.autospense.com.
Safe Harbor Notice
This press release may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities, and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the Company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company's ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the Company's business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions and other factors discussed in detail in the Company's periodic filings with the Security and Exchange Commission. The Company undertakes no obligation to update any forward-looking statements.
For further investor and media information
Todd Davis, Chairman & CEO
Green Leaf Consulting
SOURCE: Endexx Corporation